Observational Study
Copyright ©The Author(s) 2021.
World J Clin Cases. Dec 6, 2021; 9(34): 10566-10575
Published online Dec 6, 2021. doi: 10.12998/wjcc.v9.i34.10566
Table 1 Baseline characteristics of patients (n = 26) initially enrolled
Characteristic

Age (yr)52.7 ± 10.5
Sex (M/F)22/4
Alcohol/nonalcoholic6/20
Child-Pugh score 5/6/7/8/93/3/8/7/5
MELD score12.8 ± 3.8
Hepatocellular carcinoma0 (0%)
Serum albumin (gm/dL)3.2 ± 0.5
Serum bilirubin (mg/dL)2.2 ± 1.3
Prothrombin time (INR)1.4 ± 0.2
Serum creatinine1.1 ± 0.2
Presence of ascites12 (46.2%)
Presence of hepatic encephalopathy1 (3.8%)
Platelet count (K/mm3)88.1 ± 39.8
Hemoglobin (g/dL)7.8 ± 2.2
Blood transfused (units)3.0 ± 1.5
Table 2 Predictable factors of rebleeding in patients (n = 17) at the 1-yr follow-up

Rebleeding (+)
Rebleeding (-)
P value
Age (yr)55.5 ± 11.851.9 ± 10.70.533
Sex (M/F)5/91/20.728
Alcohol/nonalcoholic2/24/90.445
Child-Pugh classification A/B1/35/80.555
MELD score12.8 ± 2.613.4 ± 3.10.725
Table 3 Comparison of high-frequency intraluminal ultrasound and esophagogastroduodenoscopy for variceal rebleeding
Endoscopic modalityGOV1, n = 17 (100%)
Rebleeding (+), n = 6 (35%)
Rebleeding (–), n = 11 (65%)
P value
HFIUS≥ CSA cutoff value15 (29)2 (12)0.02
< CSA cutoff value11 (6)9 (53)
EGDGrade 1 with RCS2 (12)2 (12)0.58
Grade 0 or 1 without RCS4 (24)9 (53)